{"filing":{"accession_number":"0001493152-26-043488","cik":"0001433607","ticker":"NSPR","company_name":"InspireMD, Inc.","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-21","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/form8-k.htm"},"events":[{"id":33918,"run_id":31223,"accession_number":"0001493152-26-043488","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"InspireMD amended existing Series J and Series K warrants on September 21, 2026, modifying exercise prices and termination dates to align with anticipated FDA approval of CGuard Prime 80 cm. The amendments cover approximately 4.8 million Series J shares and 9.5 million Series K shares, with potential gross proceeds of up to $11 million if exercised. While technically an amendment to existing warrants rather than a new issuance, the modification materially enhances the likelihood and timing of exercise, effectively functioning as a dilutive capital-raising mechanism tied to a near-term regulatory milestone.","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":37513,"accession_number":"0001493152-26-043488","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"InspireMD amended existing Series J and Series K warrants on September 21, 2026, modifying exercise prices and termination dates to align with anticipated FDA approval of CGuard Prime 80 cm. The amendments cover approximately 4.8 million Series J shares and 9.5 million Series K shares, with potential gross proceeds of up to $11 million if exercised. While technically an amendment to existing warrants rather than a new issuance, the modification materially enhances the likelihood and timing of exercise, effectively functioning as a dilutive capital-raising mechanism tied to a near-term regulatory milestone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T13:13:40.181268+00:00","company_name":"InspireMD, Inc.","ticker":"NSPR","filing_date":"2026-09-21"}]}